Back to 
Verition Fund Management LLC
Verition Fund Management LLCSASAREPTA THERAPEUTICS INC
Showing 0 of 17 quarters
Position history for Verition Fund Management LLC's holdings in SAREPTA THERAPEUTICS INC
No. Verition Fund Management exited its SAREPTA THERAPEUTICS position in Q1 2023. Its Q4 2022 13F listed 16,459,000 shares worth $30.8M. Verition Fund Management first reported SAREPTA THERAPEUTICS in Q1 2019 and held it in 15 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.